scPharmaceuticals Inc. (SCPH) Cost of Revenue USD 2023 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
scPharmaceuticals Inc. quarterly/annual Cost of Revenue history and growth rate from 2023 to 2024.
  • scPharmaceuticals Inc. Cost of Revenue for the quarter ending March 31, 2024 was $1.79 M, a 195% increase year-over-year.
  • scPharmaceuticals Inc. Cost of Revenue for the twelve months ending March 31, 2024 was $4.99 M.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $4.99 M $1.79 M +$1.18 M +195% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $3.81 M $1.77 M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $1.08 M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $354 K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $605 K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.